Pyridorin in Diabetic Nephropathy
Phase 3
Terminated
- Conditions
- Diabetic NephropathyDiabetic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- NephroGenex, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT02156843
- Locations
- 🇺🇸
CSG Investigational Site (#160), Los Angeles, California, United States
🇺🇸CSG Investigational Site (#143), Riverside, California, United States
🇺🇸CSG Investigational Site (#113), Chicago, Illinois, United States
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetic Nephropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- NephroGenex, Inc.
- Target Recruit Count
- 317
- Registration Number
- NCT00734253
- Locations
- 🇺🇸
The Collaborative Study Group, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath